GFAP Out-Performs S100β in Detecting Traumatic Intracranial Lesions on Computed Tomography in Trauma Patients with Mild Traumatic Brain Injury and Those with Extracranial Lesions
- 15 November 2014
- journal article
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 31 (22) , 1815-1822
Abstract
Both glial fibrillary acidic protein (GFAP) and S100β are found in glial cells and are released into serum following a traumatic brain injury (TBI), however, the clinical utility of S100β as a biomarker has been questioned because of its release from bone. This study examined the ability of GFAP and S100β to detect intracranial lesions on computed tomography (CT) in trauma patients and also assessed biomarker performance in patients with fractures and extracranial injuries on head CT. This prospective cohort study enrolled a convenience sample of adult trauma patients at a Level I trauma center with and without mild or moderate traumatic brain injury (MMTBI). Serum samples were obtained within 4 h of injury. The primary outcome was the presence of traumatic intracranial lesions on CT scan. There were 397 general trauma patients enrolled: 209 (53%) had a MMTBI and 188 (47%) had trauma without MMTBI. Of the 262 patients with a head CT, 20 (8%) had intracranial lesions. There were 137 (35%) trauma patients who sustained extracranial fractures below the head to the torso and extremities. Levels of S100β were significantly higher in patients with fractures, compared with those without fractures ( p 0.05). The area under the receiver operating characteristics curve (AUC) for predicting intracranial lesions on CT for GFAP was 0.84 (0.73–0.95) and for S100β was 0.78 (0.67–0.89). However, in the presence of extracranial fractures, the AUC for GFAP increased to 0.93 (0.86–1.00) and for S100β decreased to 0.75 (0.61–0.88). In a general trauma population, GFAP out-performed S100β in detecting intracranial CT lesions, particularly in the setting of extracranial fractures.Keywords
This publication has 33 references indexed in Scilit:
- Systematic Review of Clinical Research on Biomarkers for Pediatric Traumatic Brain InjuryJournal of Neurotrauma, 2013
- The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injuryActa Neurochirurgica, 2011
- Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control studyCritical Care, 2011
- GFAP and S100B are biomarkers of traumatic brain injuryNeurology, 2010
- Relationship of Serum S100B Levels and Intracranial Injury in Children With Closed Head TraumaPediatrics, 2009
- S100B Is Not a Reliable Prognostic Index in Paediatric TBIPediatric Neurosurgery, 2007
- GFAP Versus S100B in Serum after Traumatic Brain Injury: Relationship to Brain Damage and OutcomeJournal of Neurotrauma, 2004
- High Serum S100B Levels for Trauma Patients without Head InjuriesNeurosurgery, 2001
- The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre studyBrain Injury, 2000
- Radioimmunoassay of serum creatine kinase BB as index of brain damage after head injury.BMJ, 1980